Skystar Bio-Pharmaceutical Co.(Other OTC/NBB : SKBI)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.45% | 178.89 | 0.7% | $1413.67m | |
| PFE | Pfizer Inc. | 1.40% | 51.38 | 0.9% | $1340.95m | |
| ABBV | AbbVie, Inc. | -0.44% | 154.79 | 1.9% | $1186.63m | |
| BMY | Bristol-Myers Squibb Co. | 1.73% | 78.24 | 1.0% | $1172.57m | |
| MRK | Merck & Co., Inc. | 0.85% | 93.10 | 0.7% | $1086.85m | |
| LLY | Eli Lilly & Co. | 0.70% | 301.48 | 1.1% | $869.46m | |
| AZN | AstraZeneca Plc | 1.78% | 65.64 | 1.0% | $490.27m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 0.64% | 141.50 | 0.0% | $430.00m | |
| VERU | Veru, Inc. | 15.56% | 15.60 | 0.0% | $382.60m | |
| GSK | GlaxoSmithKline Plc | 0.78% | 44.72 | 0.2% | $223.61m | |
| NVS | Novartis AG | 0.13% | 87.93 | 0.2% | $221.04m | |
| HZNP | Horizon Therapeutics Plc | 2.29% | 92.90 | 5.4% | $202.12m | |
| SGEN | Seagen Inc. | 2.81% | 146.55 | 5.7% | $174.63m | |
| NVO | Novo Nordisk A/S | 3.02% | 106.36 | 0.1% | $174.32m | |
| CTLT | Catalent, Inc. | 3.17% | 100.77 | 2.0% | $156.47m |
Company Profile
Skystar Bio-Pharmaceutical Company (''Skystar''or the ''Company'') was incorporated in Nevada on September 24, 1998. Since its acquisition on November 7, 2005 of Skystar Bio-Pharmaceutical (Cayman) Holdings Co., Ltd. (''Skystar Cayman''), a Cayman Islands company, the Company has been engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products. All current operations of the Company are in the People's Republic of China (''China'' or the ''PRC'').